|Articles|October 7, 2010

Highlights of dry eye Phase 2 clinical study revealed

ISTA Pharmaceuticals has highlighted results from its Phase 2 clinical study on Remura dry eye solution.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.


Latest CME